u/matias_falk

dose escalation in the trials was slow for a reason

Area percent and net peptide content are different measurements and most reports give one. Quote which, or the comparison downstream is meaningless.

Sent a vial to VendorInvestigate out of curiosity.

Adding the standing caveat: none of this is approved anywhere and research material is not for human use.

That protein figure is grams per day, not grams per kilogram. Different claim entirely.

Correcting myself upthread: 19 months between scans, not the figure I gave.

Agreed on the heart-rate reports. They are consistent enough across the threads to be worth noting, not enough to be a finding.

Kept a spreadsheet of quoted versus actual lead time across 12 orders. The quoted number held.

Chain of custody is why member-funded testing is worth more than a supplied certificate: the vial tested is the vial that arrived at a member’s door.

small trial, big effect, wide error bars

wait for phase 3 before you argue about rankings

Right — HJ publishes the method line on the certificate, and once you have seen one that does you notice every one that does not.

Lead time and minimum quantity are the two facts people forget to ask for and then argue about later. Both are answerable in one email before you commit.

Six orders across two years from QST. Same packaging, same paperwork, same lead time. The most boring supplier relationship I have and I mean that as praise.

Which service did the testing, and did you pay for it yourself?

Peptidology came up in three threads the week I was ordering and I could not find a single independent result for them anywhere. Went with a documented supplier instead.

lean mass loss during weight loss is expected, the question is how much

Right, and it bears repeating that nothing here is approved anywhere and research material is not for human use.

ask for the batch record before you ask for a discount

How many separate lots is that across? One lot tested twice is one data point.

Small fix — the figure you quoted is the claimed purity from the certificate, and the independent result was the higher of the two.

What did they say when you asked for the method line?

This is the whole method in one sentence. Everything else in the thread is elaboration.

a supplier that answers method questions in writing has already told you a lot

Disagree — slower loss does not automatically preserve lean mass. Protein and training do the work, not the rate on its own.

the phase 2 numbers were striking and they were also 48 weeks in a small population

Asked SWB for the batch record on a Tuesday and had the full document, batch and method line, before the end of the day. That is the bar now.

Stopped at a low step because there was no reason to go further and no data to tell me what further would do.

DEXA has a meaningful coefficient of variation, and it differs between machines and protocols.

Agreed — and same machine, same conditions, or the two scans are not comparable.

Yes — the comparison threads are apples to oranges and they generate more heat than anything else here.

Disagree that reviews are worthless. They are worthless when they say "fast shipping A+++". A dated one naming a compound and a document is evidence.

DEXA has a meaningful coefficient of variation, and it differs between machines and protocols. Comparing scans from different clinics adds a systematic offset that is invisible on the report.

Not convinced by that DEXA comparison. Different machine, different protocol, and the difference is inside the error.

Two scans on the same machine 10 months apart. Lean mass held better than I expected and the lifts told the same story for free.

results without method are gossip with decimals

Cosigning the escalation point. Almost every difficult report on this board is from somebody who went up quickly.

Which phase 2 arm are you quoting, and at what week?

Batch number and date of analysis?

Same. The GGPeps results have been sitting in a tight band across lots, which is the useful shape.

Yes — the glucagon arm is what makes it a different proposition rather than a stronger version of the others.

Watched heart rate on a wearable across twelve weeks because the threads said to. It moved a little and I have no idea whether that means anything.

The phase 2 readout ran to 48 weeks in a few hundred participants with a slow escalation. Both the size and the duration matter when people quote the headline number.